BIO PLEXUS INC
8-K, 1997-02-14
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: TESCORP INC, 10QSB, 1997-02-14
Next: TEMPLETON INSTITUTIONAL FUNDS INC, 485APOS, 1997-02-14



<PAGE>   1
 

                       SECURITIES AND EXCHANGE COMMISSION

                               ------------------

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934


Date of report (Date of earliest event reported)        February 6, 1997
                                                   ---------------------------

                                Bio-Plexus, Inc.
- ------------------------------------------------------------------------------
               (Exact Name of Registrant as Specified in Charter)

        Connecticut                  0-24128                 06-1211921
- ------------------------------------------------------------------------------
(State or Other Jurisdiction       (Commission             (IRS Employer
      of Incorporation)            File Number)           Identification No.)

                      384 Q Merrow Road, Tolland, CT 06084
- -------------------------------------------------------------------------------
                    (Address of Principal Executive Offices)

Registrant's telephone number, including area code     (860) 871-8601
                                                   ----------------------------

- -------------------------------------------------------------------------------
         (Former Name or Former Address, if Changed Since Last Report


<PAGE>   2

Item 9. Sale of Equity Securities Pursuant to Regulation S

        On February 6, 1997 (the "Closing Date") Bio-Plexus, Inc. (the
"Company") issued and sold an aggregate of $5,000,000 of 5% convertible
debentures due February 4, 1999 (the "Debentures"). The Debentures were sold
for cash to a single foreign institutional corporate investor organized under
the laws of the British Virgin Islands. The placement agent for the sale was
Shoreline Pacific Institutional Finance, the Institutional Division of
Financial West Group ("Shoreline Pacific"). The Debentures were issued in
reliance upon an exemption under Regulation S promulgated under the Securities
Act of 1933, as amended.

        The Debentures bear interest at the rate of five percent (5%) per annum
and are convertible into shares of common stock without par value ("Shares").
Interest is payable quarterly in arrears and accrued interest, as well as
principal, is convertible into Shares. The Debentures are convertible at a
price equal to the lesser of: (i) nine dollars ($9.00) per Share or (ii) eighty
percent (80%) of the average closing bid price of the Shares as reported by
Bloomberg, L.P. over the ten (10) day trading period ending on the day prior to
the date a notice of conversion is filed with the Company. The Debentures are
convertible into Shares in three installments over a two year period ending
February 4, 1999. In no event will the Company issue more than one million
three hundred fifty thousand (1,350,000) Shares upon conversion of the
Debentures. If such limit is reached prior to the conversion of all Debentures,
the remaining outstanding Debentures will be redeemed by the Company for
their principal amount plus accrued interest. The Debentures will be
automatically converted into Shares if the closing bid price of the Shares
equals or exceeds fourteen dollars and seventy cents ($14.70) per Share for
twenty (20) consecutive trading days during any period of time which is after
forty-five (45) days from the Closing Date. Any Debentures remaining
outstanding on February 4, 1999 also will be automatically converted into
Shares. 

        Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                        BIO-PLEXUS, INC.


                                        By /s/  Ronald A. Haverl
                                           -----------------------------------
                                                Ronald A. Haverl
                                                Chairman


Date:  February 12, 1997

<PAGE>   3


                                 EXHIBIT INDEX


Exhibit No.     Description
- -----------     ----------- 
   4.1          Form of 5% Convertible Debenture


<PAGE>   1
                                                                     EXHIBIT 4.1



THE SECURITIES OFFERED HEREBY HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED
THEREUNDER (THE "1933 ACT"), AND MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED
STATES OR TO OR FOR THE ACCOUNT OR BENEFIT OF U.S. PERSONS (AS SUCH TERMS ARE
DEFINED IN REGULATION S UNDER THE 1933 ACT), FOR A PERIOD OF FORTY-FIVE (45)
DAYS AFTER COMPLETION OF THE OFFERING PURSUANT TO WHICH THESE DEBENTURES WERE
ISSUED, AND THEREAFTER MAY ONLY BE OFFERED OR SOLD PURSUANT TO REGISTRATION
UNDER OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE 1933 ACT.



                 5% CONVERTIBLE DEBENTURE DUE [MATURITY DATE], 1999

[PRINCIPAL AMOUNT]                                         [ISSUED DATE], 1997
Number ____

         FOR VALUE RECEIVED, and subject to the terms hereof, Bio-Plexus, Inc.,
a Connecticut corporation (the "Company"), hereby promises to pay to [BUYER] a
corporation organized under the laws of [INCORP LOC], or its registered
assigns (the "Holder") on [MATURITY DATE],  (the "Maturity Date"), the
principal amount of [PRINCIPAL AMOUNT] U.S. Dollars ($), and to pay interest on
the principal amount hereof, in such amounts, at such times and on such terms
and conditions as are specified herein. This Debenture is one of [DEB NO]
Debentures (the "Debentures") issued by the Company to the Holder, each in
the principal amount of $ [DEB AMOUNT] U.S., for an aggregate purchase price of
[PURCHASE PRICE] U.S. Dollars ($).

ARTICLE 1.  Interest

         The Company shall pay interest on the unpaid principal amount of this
Debenture (this "Debenture") at the rate of Five Percent (5%) per year, payable
quarterly in arrears in cash beginning on April 30, 1997, until the principal
hereof is paid in full or has been converted. Interest on this Debenture shall
accrue from the most recent date to which interest has been paid or, if no
interest has been paid, from [ISSUED DATE]. Interest shall be computed on the
basis of a 360-day year of twelve 30-day months.

ARTICLE 2.  Method of Payment

         This Debenture must be surrendered to the Company in order for the
Holder to receive payment of the principal amount hereof. The Company shall pay
the principal of and interest on this Debenture in United States Dollars.
However, the Company may pay principal and interest by a check payable in such
money. The Company may draw a check for the payment of interest to the order of
the Holder of this Note and mail it to the Holder's address as shown on the
Register (as defined in Section 7.2 below). Interest and principal payments
shall be subject to withholding under applicable United States Federal Internal
Revenue Service Regulations.
<PAGE>   2
5% Convertible Debenture
Page 2



ARTICLE 3.  Conversion

         SECTION 3.1.  Conversion Privilege

         (a) The Holder of the Debentures shall have the right, at its option
and subject to the provisions of this Section 3.1, to convert the Debentures
into shares of common stock, no par value per share, of the Company ("Common
Stock") before the close of business on the Maturity Date as follows: up to
one-third of the total aggregate principal amount of the Debentures is
convertible on or after 45 days from the closing of the purchase hereof (the
"Closing"), with an additional one-third convertible on or after 75 days from
Closing, and the remaining one-third convertible on or after 105 days from
Closing. The number of shares of Common Stock issuable upon the conversion of
this Debenture is determined by dividing the principal amount hereof to be
converted plus all accrued interest thereon minus any required withholding by
the conversion price in effect on the conversion date (as defined in paragraph
(b) of this Section 3.1 below) and rounding the result to the nearest 1/100th of
a share. On conversion, no payment of or adjustment (other than as provided in
the previous sentence) for accrued interest shall be made whether or not such
conversion occurs before, on or after an interest payment date.

         (b) The Debentures will be convertible into Common Stock at the lesser
of Nine Dollars U.S. ($9.00) per Common Share or eighty percent (80%) of the
average closing bid price of the Company's Common Stock, as reported by
Bloomberg, L.P., over the ten (10) day trading period ending on the day prior to
the date the notice of conversion is filed with the Company.

         (c) Less than all of the principal amount of the Debentures may be
converted into Common Stock if the portion converted is $10,000 or a whole
multiple of $10,000 and the provisions of this Section 3 that apply to the
conversion of all of the Debentures also apply to the conversion of a portion
thereof. All accrued interest on this Debenture shall be added to the amount
converted if less than all of the principal amount of this Debenture is
converted and shall be deemed to be paid and discharged thereby.

         (d) In the event any portion of the Debentures remains outstanding on
the second anniversary of the date hereof, the unconverted portion of the
Debentures will automatically be converted into shares of Common Stock on such
date in the manner set forth in this Section 3.1.

         (e) Notwithstanding the above-stated provisions, the Company may issue
no more than 1,350,000 Common Shares upon conversion of any or all of the
Debentures totaling $5,000,000. In the event that limit is reached before the
Holder has fully converted all of the Debentures, the Company shall redeem the
outstanding portion thereof at the price
<PAGE>   3
5% Convertible Debenture
Page 3



paid therefor by the Holder, plus any accrued but unpaid interest, within ten
(10) business days of the date on which the 1,350,000 Common Share limit was
reached.

         (f) In the event the closing bid price (defined in Section 3.7(b)) for
the shares of the Company's Common Stock equals or exceeds $14.70 per share for
twenty (20) consecutive trading days during any period of time which is after
forty-five (45) days from the Closing, all outstanding Debentures will
automatically be converted into shares of Common Stock in the manner set forth
in this Section 3.1. Such conversion shall occur within ten (10) business days
following the end of the twenty (20) trading day period described in the
foregoing sentence.

         SECTION 3.2. Conversion Procedure. To convert this Debenture into
Common Stock, the Holder must (a) complete and sign the Notice of Conversion
attached hereto, (b) surrender the Debenture to the Company, (c) furnish
appropriate endorsements and transfer documents if so requested by the Company
and (d) subject to Section 3.4 pay any transfer or similar tax if required by
the Company. The conversion date shall be the date upon which the Company
receives both the completed Notice of Conversion (by mail, facsimile or
otherwise) and the original Debentures to be converted. Within three (3)
business days after receipt of the Notice of Conversion and original Debentures
to be converted, the Company shall deliver an unlegended certificate for the
number of full shares of Common Stock issuable upon the conversion and a check
for any fraction of a share. The person in whose name the certificate of Common
Stock is to be registered shall be treated as a shareholder of record on and
after the conversion date. No payment or adjustment shall be made for accrued
interest on a converted Debenture whether the conversion date is on, at or after
an interest payment date. If one person converts more than one Debenture at the
same time, the number of full shares issuable upon the conversion shall be based
on the total principal amount of Debentures converted. Upon surrender of a
Debenture that is to be converted in part, the Company shall issue to the Holder
a new Debenture equal in principal amount to the unconverted portion of the
Debenture surrendered.

         SECTION 3.3. Fractional Shares. The Company shall not issue a
fractional share of Common Stock upon the conversion of this Debenture. Instead,
the Company shall pay in lieu of any fractional share the cash value thereof at
the then current market price of the Common Stock as determined under Section
3.7 below.

         SECTION 3.4. Taxes on Conversion. The Company shall pay any
documentary, stamp or similar issue or transfer tax due on the issue of shares
of Common Stock upon the conversion of this Debenture. However, the Holder shall
pay any such tax which is due because the shares are issued in a name other than
its name.

         SECTION 3.5. Company to Reserve Stock. The Company shall reserve out of
its authorized but unissued Common Stock or Common Stock held in treasury enough
shares of Common Stock to permit the conversion of this Debenture. All shares of
Common
<PAGE>   4
5% Convertible Debenture
Page 4



Stock which may be issued upon the conversion hereof shall be fully paid
and nonassessable.

         SECTION 3.6. Restrictions on Transfer. This Debenture and the Common
Stock issuable upon the conversion hereof have not been registered under the
Securities Act of 1933 (the "Act") and have been sold pursuant to Regulation S
under the Act ("Regulation S"). The Debentures may not be transferred or resold
in the United States, or to a U.S. Person, or to or for the account or benefit
of a U.S. Person (as defined in Regulation S) for a period of forty-five (45)
days from the date hereof and thereafter may only be offered or sold pursuant to
registration under or an exemption from the Act.

         SECTION 3.7.  Current Market Price.

         (a) In Sections 3.1 and 3.3, the current market price per share of
Common Stock on any date is the average of the closing bid price of the Common
Stock over the ten (10) day trading day period ending on the day prior to the
date the Notice of Conversion is filed with the Company.

         (b) As used in this Section 3.7, the term closing bid price shall mean
(i) the closing bid price of the Company's Common Stock on any such trading
date, as reported by Bloomberg, L.P. or (ii) in the event the Common Stock is
not reported on such system, the fair market value of the Common Stock as
determined by the Board of Directors of the Company in its good faith judgment.

         SECTION 3.8. Mergers, Etc. If the Company merges or consolidates with
another corporation or sells or transfers all or substantially all of its assets
to another person and the holders of the Common Stock are entitled to receive
stock, securities or property in respect of or in exchange for Common Stock,
then as a condition of such merger, consolidation, sale or transfer, the Company
and any such successor, purchaser or transferee shall amend this Debenture to
provide that it may thereafter be converted on the terms and subject to the
conditions set forth above into the kind and amount of stock, securities or
property receivable upon such merger, consolidation, sale or transfer by a
holder of the number of shares of Common Stock into which this Debenture might
have been converted immediately before such merger, consolidation, sale or
transfer.

ARTICLE 4.  Mergers

         The Company shall not consolidate or merge into, or transfer all or
substantially all of its assets to, any person, unless such person assumes the
obligations of the Company under this Debenture and immediately after such
transaction no Event of Default (as defined below) exists. Any reference herein
to the Company shall refer to such surviving or transferee corporation and the
obligations of the Company shall terminate upon such assumption.
<PAGE>   5
5% Convertible Debenture
Page 5



ARTICLE 5.  Reports

         The Company will mail to the Holder hereof at its address as shown on
the Register a copy of any annual, quarterly or current report that it files
with the Securities and Exchange Commission promptly after the filing thereof
and a copy of any annual, quarterly or other report or proxy statement that it
gives to its shareholders generally at the time such report or statement is sent
to shareholders.

ARTICLE 6.  Defaults and Remedies

         SECTION 6.1. Events of Default. An "Event of Default" occurs if (a) the
Company does not make the payment of the principal of this Debenture when the
same becomes due and payable at maturity, upon redemption or otherwise, (b) the
Company does not make a payment of interest when such interest becomes due and
payable and such default continues for a period of 5 days thereafter, (c) the
Company fails to issue shares of Common Stock upon conversion, (d) the Company
fails to comply with any of its other agreements in this Debenture and such
failure continues for the period and after the notice specified below, (e) the
Company pursuant to or within the meaning of any Bankruptcy Law (as hereinafter
defined): (i) commences a voluntary case; (ii) consents to the entry of an order
for relief against it in an involuntary case; (iii) consents to the appointment
of a Custodian (as hereinafter defined) of it or for all or substantially all of
its property; (iv) makes a general assignment for the benefit of its creditors;
or (v) a court of competent jurisdiction enters an order or decree under any
Bankruptcy Law that: (A) is for relief against the Company in an involuntary
case; (B) appoints a Custodian of the Company or for all or substantially all of
its property or (C) orders the liquidation of the Company, and the order or
decree remains unstayed and in effect for 60 days. As used in this Section 6.1,
the term "Bankruptcy Law" means Title 11 of the United States Code or any
similar federal or state law for the relief of debtors. The term "Custodian"
means any receiver, trustee, assignee, liquidator or similar official under any
Bankruptcy Law. A default under clause (d) above is not an Event of Default
until the holders of at least 25% of the aggregate principal amount of the
Debentures notify the Company of such default and the Company does not cure it
within 5 days after the receipt of such notice, which must specify the default,
demand that it be remedied and state that it is a "Notice of Default."

         SECTION 6.2. Acceleration. If an Event of Default occurs and is
continuing, the Holder hereof by notice to the Company, may declare the
principal of and accrued interest on this Debenture to be due and payable. Upon
such declaration, the principal and interest hereof shall be due and payable
immediately.


ARTICLE 7.  Registered Debentures
<PAGE>   6
5% Convertible Debenture
Page 6



         SECTION 7.1. Series. This Debenture is one of a numbered series of
[DEB NO] Debentures, each in the principal amount of $ [DEB AMOUNT], for a
total aggregate principal amount of [PURCHASE AMOUNT], which are identical
except as to any restriction on the conversion or transfer thereof in order
to comply with the terms hereof, the Securities Act of 1933 and the
regulations of the Securities and Exchange Commission promulgated thereunder.

         SECTION 7.2. Record Ownership. The Company shall maintain a register of
the holders of the Debentures (the "Register") showing their names and addresses
and the serial numbers and principal amounts of Debentures issued to or
transferred of record by them from time to time. The Register may be maintained
in electronic, magnetic or other computerized form. The Company may treat the
person named as the Holder of this Debenture in the Register as the sole owner
of this Debenture. The Holder of this Debenture is the person exclusively
entitled to receive payments of interest on this Debenture, receive
notifications with respect to this Debenture, convert it into Common Stock and
otherwise exercise all of the rights and powers as the absolute owner hereof.

         SECTION 7.3. Registration of Transfer. Transfers of this Debenture may
be registered on the books of the Company maintained for such purpose pursuant
to Section 7.2 above (i.e., the Register). Transfers shall be registered when
this Debenture is presented to the Company with a request to register the
transfer hereof and the Debenture is duly endorsed by the appropriate person,
reasonable assurances are given that the endorsements are genuine and effective,
and the Company has received evidence satisfactory to it that such transfer is
rightful and in compliance with all applicable laws, including tax laws and
state and federal securities laws. When this Debenture is presented for transfer
and duly transferred hereunder, it shall be canceled and a new Debenture showing
the name of the transferee as the record holder thereof shall be issued in lieu
hereof. When this Debenture is presented to the Company with a reasonable
request to exchange it for an equal principal amount of Debentures of other
denominations, the Company shall make such exchange and shall cancel this
Debenture and issue in lieu thereof Debentures having a total principal amount
equal to this Debenture in the denominations requested by the Holder. The
Company may charge a reasonable fee for any registration of transfer or exchange
other than one occasioned by a notice of redemption or the conversion hereof.

         SECTION 7.4. Worn and Lost Debentures. If this Debenture becomes worn,
defaced or mutilated but is still substantially intact and recognizable, the
Company or its agent may issue a new Debenture in lieu hereof upon its
surrender. Where the Holder of this Debenture claims that the Debenture has been
lost, destroyed or wrongfully taken, the Company shall issue a new Debenture in
place of the original Debenture if the Holder so requests by written notice to
the Company actually received by the Company before it is notified that the
Debenture has been acquired by a bona fide purchaser and the Holder has
delivered to the Company an indemnity bond in such amount and issued by such
surety as the Company deems satisfactory together with an affidavit of the
Holder setting forth the facts concerning such loss, destruction or wrongful
taking and such other information in
<PAGE>   7
5% Convertible Debenture
Page 7



such form with such proof or verification as the Company may request.

ARTICLE 8.  Notices

         Except as otherwise provided in this Debenture, any notice which is
required or convenient under the terms of this Debenture shall be duly given if
it is in writing and (a) delivered in person (b) mailed by first class mail,
postage prepaid, or (c) sent by private overnight mail service (such as Federal
Express) and directed to the Holder of the Debenture at its address as it
appears on the Register or if to the Company to its principal executive offices.
Such notice shall be effective, when personally delivered, upon receipt, when so
sent by first class mail, four business days after deposit with the United
States Postal Service, or when so sent by private overnight mail service, the
next business day after deposit.

ARTICLE 9.  Time

         Where this Debenture authorizes or requires the payment of money or the
performance of a condition or obligation on a Saturday or Sunday or a public
holiday, or authorizes or requires the payment of money or the performance of a
condition or obligation within, before or after a period of time computed from a
certain date, and such period of time ends on a Saturday or a Sunday or a public
holiday, such payment may be made or condition or obligation performed on the
next succeeding business day, and if the period ends at a specified hour, such
payment may be made or condition performed, at or before the same hour of such
next succeeding business day, with the same force and effect as if made or
performed in accordance with the terms of this Debenture. Where time is extended
by virtue of the provisions of this Article 9, such extended time shall not be
included in the computation of interest.


ARTICLE 10.  Waivers

         The holders of a majority in principal amount of the Debentures may
waive a default or rescind the declaration of an Event of Default and its
consequences except for a default in the payment of principal of or interest on
any Debenture.
<PAGE>   8
5% Convertible Debenture
Page 8



ARTICLE 11.  Rules of Construction

         In this Debenture, unless the context otherwise requires, words in the
singular number include the plural, and in the plural include the singular, and
words of the masculine gender include the feminine and the neuter, and when the
sense so indicates, words of the neuter gender may refer to any gender. The
numbers and titles of sections contained in this Debenture are inserted for
convenience of reference only, and they neither form a part of this Debenture
nor are they to be used in the construction or interpretation hereof. Wherever,
in this Debenture, a determination of the Company is required or allowed, such
determination shall be made by a majority of the Board of Directors of the
Company and if it is made in good faith, it shall be conclusive and binding upon
the Company and the Holder of this Debenture.

ARTICLE 12.  Governing Law

         The validity, terms, performance and enforcement of this Debenture
shall be governed and construed by the provisions hereof and in accordance with
the laws of the State of New York applicable to agreements that are negotiated,
executed, delivered and performed solely in the State of New York.

         IN WITNESS WHEREOF, the Company has duly executed this Debenture as of
the date first written above.

                                            Bio-Plexus, Inc.


                                            By__________________________________
                                                     Ronald A. Haverl
                                                     Chief Executive Officer
<PAGE>   9
5% Convertible Debenture
Page 9



                              NOTICE OF CONVERSION

         [To be completed and signed only upon conversion of Debenture]

         The undersigned, the Holder of this Debenture, hereby elects to
exercise the right to convert it into common stock, no par value per share, of
Bio-Plexus, Inc. as follows:

<TABLE>
<S>                                      <C>
[Complete if less than                   ____________________Dollars ($__________)*___
all of principal amount                  ($10,000 or integral multiples of $10,000)
is to be converted]

[Signature must be                       _____________________________________________
guaranteed if registered                 (Name of Holder of shares if different than
holder of stock differs from             registered Holder of Debenture)
registered Holder of
Debenture]
                                         _____________________________________________
                                        (Address of Holder if different than address of
                                        registered Holder of Debenture)


                                         _____________________________________________
                                        (Social Security or EIN of Holder of shares if
                                        different than Holder of Debenture)
</TABLE>

         *If the principal amount of the Debenture to be converted is less than
the entire principal amount thereof, a new Debenture for the balance of the
principal amount shall be returned to the Holder of the Debenture.

<TABLE>
<S>                                      <C>
Date:________________                    Sign:________________________________________
                                              (Signature must conform in all respects
                                               to name of Holder shown on face of this
                                               Debenture)
</TABLE>

Signature Guaranteed:
<PAGE>   10
5% Convertible Debenture
Page 10



                             Assignment of Debenture


        The undersigned hereby sell(s) and assign(s) and transfer(s) unto
    ________________________________________________________________________
                   (name, address and SSN or EIN of assignee)

__________________________________________________Dollars ($_________)______
(principal amount of Debenture, $10,000 or integral multiples of $10,000)

of principal amount of this Debenture together with all accrued interest hereon.


Date:________                   Sign:__________________________________________
                                     (Signature must conform in all respects to
                                      name of Holder shown on face of Debenture)


Signature Guaranteed:


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission